Advertisement
Home Tags Meningitis

Tag: Meningitis

Pharmacy Exec Behind Meningitis Outbreak Gets Longer Prison Sentence

President and co-owner of the New England Compounding Center received a 14.5-year sentence from a federal judge Wednesday

Major Neurological Disorders on the Rise in the United States

Burden increasing largely due to aging of the U.S. population

Routine vaccination with a quadrivalent meningococcal conjugate vaccine is recommended for adolescents aged 11 to 12 years with a booster at age 16 years

ACIP Provides Recommendations on Meningococcal Vaccination

Vaccination with MenACWY recommended for adolescents aged 11 to 12 years with booster at 16 years
The decrease in vaccination orders seen during the COVID-19 pandemic could offset increases in vaccinations for adolescents from 2018 to 2019

Adolescent Vaccinations Decreased During COVID-19 Pandemic

Decrease could offset increased coverage noted from 2018 to 2019 in HPV vaccination, MenACWY
Coverage with the human papillomavirus vaccine increased among boys from 2017 to 2018

Coverage With HPV Vaccine Continuing to Increase in Boys

Teens whose parents received a provider recommendation had higher coverage with HPV vaccine
Metagenomic next-generation sequencing of cerebrospinal fluid obtained from patients with meningitis or encephalitis can improve diagnosis of neurologic infections

Next-Gen Sequencing of CSF Improves Diagnosis of CNS Infections

Eight of 13 diagnoses made solely by metagenomic NGS had likely clinical effect, seven guided treatment
Achieving high serogroup B meningococcal vaccination coverage is recommended following university-based outbreaks of meningococcal disease caused by serogroup B

High Rates of MenB Vaccination Advised in University Outbreaks

Estimated first-dose vaccination coverage varied from 14 to 98 percent in 10 university outbreaks
College students have an increased risk for sporadic and outbreak-associated serogroup B meningococcal disease

College Students at Increased Risk for SgB Meningococcal Dz

Students, parents, health care providers should be aware of the availability of MenB vaccines
Universal vaccination against Neisseria meningitidis serogroup B at college entry does not appear to be cost-effective

Universal Vaccination for MenB at College Entry Not Cost-Effective

Incremental cost per quality-adjusted life-year gained $13.8 million under societal perspective
U.S. pediatricians and family physicians have considerable knowledge gaps regarding serogroup B meningococcal vaccination

Physicians Lack Knowledge About Serogroup MenB Vaccination

Primary care docs who are somewhat or not aware of MenB vaccine are less likely to discuss vaccination